Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Alemtuzumab 30, T-prolymphocytic leukemia, cycle 2+

Protocol-ID: 1549 V1.0 (Mini), ALEM30, T-PLL, C2+

Indication(s)

  • T-Cell Prolymphocyte Leukemia; ICD-10 C91.6-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 07.07.2020